Therefore, it provides a target for designing inhibitors that will enable β-cell regeneration—leading to a reduction in insulin producing cell loss in type I diabetes (T1D) and increased insulin production in type II diabetes (T2D) [7, 8]. The gene discussed is INS; the disease is type 2 diabetes mellitus.